Gamelin Erick (CIK 1950551) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-20). Recent activity: Buy ACRV (38,584 shares), Sell ACRV (404 shares), Sell ACRV (471 shares), Sell ACRV (403 shares), Sell ACRV (403 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-20 | Acrivon Therapeutics, Inc. (ACRV) | Chief Development Officer | Buy | 38,584 | $0 |
| 2026-05-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Development Officer | Sell | 404 | $776 |
| 2026-02-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Development Officer | Sell | 471 | $768 |
| 2025-11-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Development Officer | Sell | 403 | $903 |
| 2025-08-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Development Officer | Sell | 403 | $560 |
| 2025-05-16 | Acrivon Therapeutics, Inc. (ACRV) | Chief Development Officer | Sell | 403 | $459 |
| 2025-02-19 | Acrivon Therapeutics, Inc. (ACRV) | Chief Development Officer | Sell | 469 | $2,542 |
Source: SEC Form 4 filings · as of 2026-05-20